instrument purchase | GenomeWeb

instrument purchase

The Alameda, California-based firm is embarking on an internal validation study for its lung cancer liquid biopsy and is seeking to build a CLIA-certified lab.

The instruments will be housed at the new Metabolomics Technology Demonstration Centre and will help firms translate biomarkers into clinical tests.

The UK Biobank will use Trinean's technology to quantify molecules during the DNA extraction stage of a large genotyping project.

NEW YORK (GenomeWeb News) – The National Institutes of Health expects to award $43 million in 2014 to help research centers buy new or upgrade existing instruments for use in genomics, mass spectrometry, imaging, microscopy, and a range of other biomedical research areas.

NEW YORK (GenomeWeb News) — The New York Genome Center launched its "Innovation Center" today, which will provide its founding members with access to new sequencing technologies.

NEW YORK (GenomeWeb News) – RainDance Technologies today said that it has completed a collaboration with MLL Munich Leukemia Laboratory on the development of a panel for use in the sequence-based analysis of acute myeloid leukemia and myelodysplastic syndromes.

NEW YORK (GenomeWeb News) – The Hospital for Sick Children (SickKids) in Toronto has launched a new Centre for Genetic Medicine and plans to install four of Life Technologies' Ion Proton machines.

Agilent will equip the National University of Singapore Environmental Research Institute with instruments for chemical and bioanalysis and electronic measurements that it will use to study water, air, soil, food, and biospecimens.

The deals announced today are with the Institute of Medical Microbiology, Francisco Soria Melguizo, and Viollier.

Spending on life science tools rose 13 percent in the fourth quarter of 2010, suggesting that the "effects of the continuing resolution on NIH budgets have not dampened the underlying demand for tools in the US academic sector."

Pages

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.